These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 7938333)

  • 1. Psychosocial treatment for obsessive-compulsive disorder.
    Munford PR; Hand I; Liberman RP
    Psychiatry; 1994 May; 57(2):142-52. PubMed ID: 7938333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term follow-up and predictors of clinical outcome in obsessive-compulsive patients treated with serotonin reuptake inhibitors and behavioral therapy.
    Alonso P; Menchon JM; Pifarre J; Mataix-Cols D; Torres L; Salgado P; Vallejo J
    J Clin Psychiatry; 2001 Jul; 62(7):535-40. PubMed ID: 11488364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Resistance and refractoriness in obsessive-compulsive disorder].
    Ferrão YA; Diniz JB; Lopes AC; Shavitt RG; Greenberg B; Miguel E
    Braz J Psychiatry; 2007 Oct; 29 Suppl 2():S66-76. PubMed ID: 18172943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combination treatment in children and adolescent with obsessive compulsive disorders].
    Wewetzer C; Walitza S
    MMW Fortschr Med; 2005 Dec; 147(48):36, 38-40. PubMed ID: 16389860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of combination of fluoxetine and cognitive behavioral therapy and fluoxetine alone for the treatment of obsessive compulsive disorder.
    Giasuddin NA; Nahar JS; Morshed NM; Balhara YP; Sobhan MA
    Pak J Pharm Sci; 2013 Jan; 26(1):95-8. PubMed ID: 23261733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obsessive compulsive disorder and depression--first results of a prospective study on 74 patients.
    Demal U; Zitterl W; Lenz G; Zapotoczky HG; Zitterl-Eglseer K
    Prog Neuropsychopharmacol Biol Psychiatry; 1996 Jul; 20(5):801-13. PubMed ID: 8870065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic management of obsessive-compulsive disorder.
    Jackson CW; Morton WA; Lydiard RB
    South Med J; 1994 Mar; 87(3):310-21. PubMed ID: 8134850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cognitive-behavior therapy for obsessive-compulsive disorder: a systematic review of the last decade].
    Prazeres AM; Souza WF; Fontenelle LF
    Braz J Psychiatry; 2007 Sep; 29(3):262-70. PubMed ID: 17713699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing the patient with treatment-resistant obsessive compulsive disorder: current strategies.
    Jenike MA; Rauch SL
    J Clin Psychiatry; 1994 Mar; 55 Suppl():11-7. PubMed ID: 7915709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral therapy in children and adolescents with obsessive-compulsive disorder: a pilot study.
    Scahill L; Vitulano LA; Brenner EM; Lynch KA; King RA
    J Child Adolesc Psychopharmacol; 1996; 6(3):191-202. PubMed ID: 9231312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obsessive-compulsive disorder. Diagnosis and management.
    Ladouceur R; Freeston M; Gagnon F
    Can Fam Physician; 1996 Jun; 42():1169-72, 1175-8. PubMed ID: 8704492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating obsessive-compulsive disorder. Options include medication, psychotherapy, surgery, and deep brain stimulation.
    Harv Ment Health Lett; 2009 Mar; 25(9):4-5. PubMed ID: 19368037
    [No Abstract]   [Full Text] [Related]  

  • 13. Addition of cognitive-behaviour therapy for obsessive-compulsive disorder patients non-responding to fluoxetine.
    Kampman M; Keijsers GP; Hoogduin CA; Verbraak MJ
    Acta Psychiatr Scand; 2002 Oct; 106(4):314-9. PubMed ID: 12225499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoxetine versus phenelzine in obsessive-compulsive disorder.
    Golwyn DH; Sevlie CP
    Am J Psychiatry; 1999 Jan; 156(1):159-60. PubMed ID: 9892321
    [No Abstract]   [Full Text] [Related]  

  • 15. Group cognitive-behavioral therapy versus selective serotonin reuptake inhibitors for obsessive-compulsive disorder: a practical clinical trial.
    Belotto-Silva C; Diniz JB; Malavazzi DM; Valério C; Fossaluza V; Borcato S; Seixas AA; Morelli D; Miguel EC; Shavitt RG
    J Anxiety Disord; 2012 Jan; 26(1):25-31. PubMed ID: 21907540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of fluoxetine on various subtypes of obsessive-compulsive disorder.
    Farnam A; Goreishizadeh MA; Farhang S
    Arch Iran Med; 2008 Sep; 11(5):522-5. PubMed ID: 18759519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of CBT with fluoxetine works better for obsessive-compulsive disorder.
    Giasuddin NA; Nahar JS; Morshed NM; Balhara YP
    Asian J Psychiatr; 2012 Mar; 5(1):113. PubMed ID: 26878959
    [No Abstract]   [Full Text] [Related]  

  • 18. Obsessive compulsive disorder.
    Soomro GM
    Clin Evid; 2004 Jun; (11):1319-34. PubMed ID: 15652061
    [No Abstract]   [Full Text] [Related]  

  • 19. Obsessive-compulsive disorder issues pertinent to women.
    Nestadt G
    Womens Health (Lond); 2008 Jul; 4(4):311-3. PubMed ID: 19072494
    [No Abstract]   [Full Text] [Related]  

  • 20. Cognitive-behavioral therapy as an adjunct to serotonin reuptake inhibitors in obsessive-compulsive disorder: an open trial.
    Simpson HB; Gorfinkle KS; Liebowitz MR
    J Clin Psychiatry; 1999 Sep; 60(9):584-90. PubMed ID: 10520976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.